Business Day (Johannesburg)
7 July 2009
AFTER rejecting an unsolicited bid from rival Adcock Ingram, generic drug maker Cipla Medpro SA (CMSA) is focusing efforts on further expanding its domestic market share supported by a pipeline of drugs to be supplied by strategic partner Cipla India.
[ See Article ]
